February 2016

Read more about Indian scientists unlocking betel leaf's health secrets

The next time you hear the words "Meetha patta" or "Madrasi patta", don't ignore the humble heart-shaped popular mouth-freshener. Paan or betel leaf could provide the key to unlock an arsenal of anti-inflammatory drugs, claim Indian researchers.

1 February 2016

Career as Process Chemist, Officer and executive in QA, RA at SeQuent

SeQuent is looking towards the future with courage and confidence, because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation) and Human health (API).

Read more about Virtual reality headsets can trigger motion sickness, nausea

Regular virtual reality (VR) headset-users who play motion-heavy videos suffer the most from motion sickness and nausea, researchers have found.

Read more about Obesity, diabetes up autism risk in kids

Women of reproductive age who are thinking of having children should stay fit. A recent study warns that children born to obese women with diabetes are four times more likely to be diagnosed with autism spectrum disorder.

Read more about How rats respond to fear can fix stress disorder in humans

Female rats often respond to fear by "darting" where they start running around like crazy when they sense threat, new research has found, suggesting that the findings could lead to better treatments for post-traumatic stress disorder (PTSD) in humans.

Read more about Two vector-borne diseases that pass from mother to child

The US researchers have identified two life-threatening vector-borne diseases that can be passed from mother to child through the placenta.

1 February 2016

Opening in Maintenance, QC and Production department @ Mysore - API Plant

Read more about USAID to offer 21 million USD to make India TB free

The U.S. Agency for International Development (USAID) today announced three new awards to support the Government of India’s efforts to end tuberculosis (TB) in India.

Read more about AbbVie Initiates Enrollment in Phase 3 Clinical Program for Elagolix

AbbVie , in cooperation with Neurocrine Biosciences, Inc. announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.

Read more about OptiNose Announces FDA Approval for ONZETRA™ Xsail™

OptiNose, a privately-held specialty biopharmaceutical company, announced that its licensing partner, Avanir Pharmaceuticals, Inc. has reported that the U.S. Food & Drug Administration (FDA) approved ONZETRA™ Xsail™ (sumatriptan nasal powder), formerly AVP-825, for the acute treatment of migraine with or without aura in adults. ONZETRA Xsail is the first product developed by OptiNose to receive FDA approval and is an intranasal medication delivery system using the novel Xsail Breath Powered Delivery Device.